Skip to main content
. 2019 Jan 29;8(2):151. doi: 10.3390/jcm8020151

Table 1.

Baseline characteristics in patients who failed to show a maintained response (Group I) and those with a maintained response (Group II) after TRT cessation.

Group I Group II p-Value
N (%) 92/151 (60.9) 59/151 (30.1)
Age (years) 61.1 ± 9.3 60.4 ± 7.7 0.669
BMI (kg/m2) 25.0 ± 2.8 24.9 ± 2.6 0.745
Waist (cm) 86.5 ± 6.8 86.0 ± 6.2 0.640
Comorbidities, N 0.095
None 32/92 19/59
HTN 28/92 18/59
DM 18/92 13/59
Dyslipidemia 8/92 7/59
Hepatobiliary disease 8/92 4/59
Pulmonary disease 9/92 5/59
Chronic kidney disease 8/92 3/59
Alcohol, N 0.753
65/92 41/59
Smoking, N 0.654
13/92 4/59
Exercise, N 0.000
Yes 9/92 32/59
No 83/92 27/59
IIEF total 27 ± 14.18 29.34 ± 14.1 0.323
Erectile function 11.02 ± 7.03 12.20 ± 7.08 0.316
Orgasmic function 3.71 ± 3.39 4.14 ± 3.35 0.447
Sexual desire 4.23 ± 1.80 4.46 ± 1.87 0.453
Intercourse satisfaction 4.32 ± 3.10 4.68 ± 3.03 0.480
Overall satisfaction 4.05 ± 1.78 4.20 ± 1.81 0.619
AMS total 38.52 ± 9.37 38.86 ± 9.69 0.829
Psycho 9.33 ± 3.63 9.46 ± 3.59 0.827
Somato 14.50 ± 4.27 14.46 ± 4.23 0.952
Sexual 14.70 ± 4.25 14.95 ± 4.32 0.723
PSA (ug/dL) 1.06 ± 0.71 1.07 ± 0.73 0.953
Hb (g/dL) 14.76 ± 1.09 14.82 ± 1.17 0.755
Hct (%) 42.92 ± 3.11 42.70 ± 2.85 0.662
Glucose (mg/dL) 106.86 ± 24.72 105.03 ± 20.54 0.638
Total Cholesterol (mg/dL) 176.12 ± 35.65 181.20 ± 40.24 0.418
TG (mg/dL) 220.01 ± 219.83 233.54 ± 235.79 0.726
HDL (mg/dL) 48.53 ± 10.27 46.96 ± 9.26 0.355
LDL (mg/dL) 114.44 ± 25.93 120.49 ± 30.79 0.206

p-value, compared between two groups; BMI, body mass index; HTN, hypertension; DM, diabetes mellitus; IIEF, International Index of Erectile Function; AMS, Aging Males’ Symptoms Score; PSA, prostate-specific antigen; Hb, hemoglobin; Hct, hematocrit; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein.